Residual Beta Cell Function in Newly Diagnosed Type 1 Diabetes after Treatment with Atorvastatin: The Randomized DIATOR Trial

BACKGROUND: Recent evidence suggests that the lipid-lowering agent atorvastatin is also a potent immunomodulator. The aim of this study was to investigate the possible effect of atorvastatin on the decline of residual beta cell function in recent-onset type 1 diabetes. METHODS AND FINDINGS: The rand...

Full description

Saved in:
Bibliographic Details
Main Authors: Martin, Stephan, Herder, Christian, Schloot, Nanette C., Koenig, Wolfgang, Heise, Tim, Heinemann, Lutz, Kolb, Hubert
Format: Artigo
Language:Inglês
Published: Public Library of Science 2011
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3055882/
https://ncbi.nlm.nih.gov/pubmed/21412424
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0017554
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items